Sarcopenia significantly increases risk of cardiometabolic diseases and death among elderly, reveals research
Sarcopenia significantly increased the risk of cardiometabolic diseases (CMDs), cardiometabolic multimorbidity (CMM), and death in middle-aged and older adults. A study of 413,326 CMD-free participants followed for 13.1 years found those with severe sarcopenia faced a 42% higher risk of progressing to a single CMD and a 69% higher risk of developing CMM, with more than double the risk of death (HR 2.05-2.05)
Although sarcopenia has been linked to a range of cardiometabolic diseases (CMDs, including coronary heart disease [CHD], stroke, and diabetes here), its role in the temporal progression from healthy to single CMD, subsequently to cardiometabolic multimorbidity (CMM, coexistence of ≥ 2 CMDs in an individual), and further to death remains unclear. In this study, we aimed to examine the associations of sarcopenia with the risk of CMDs, CMM, and mortality along the CMD progression trajectory.
They used data from UK Biobank of 413,326 participants free of CMDs at baseline. Multi-state models were used to analyze the transition-specific associations of sarcopenia status measured by handgrip strength, muscle mass, and gait speed (according to the 2019 European Working Group of Sarcopenia in Older People 2) with the progression from no CMD to single CMD, CMM, and ultimately to death. The role of specific sarcopenia components was also assessed.
Results: During a median follow-up of 13.1 years, 51,705 participants experienced ≥ 1 CMD, 6,003 had CMM, and 24,495 died. Compared with people free of sarcopenia, participants with confirmed/severe sarcopenia had higher risk experiencing transitions from no CMD to single CMD or death (hazard ratio [HR] 1.42 and 2.08) and also higher risk from single CMD to CMM progression or death (HR 1.69 and 2.05). Significant associations were observed for participants with probable sarcopenia with smaller effect sizes. All three sarcopenia components increased the risk of most transitions, and stronger associations were observed for low gait speed.
In stratified analyses, the associations between sarcopenia and mortality-related transitions were modified by specific lifestyles. Sarcopenia is an independent risk factor of CMD, CMM progression, and all-cause mortality among middle-aged and older people.
Reference:
Xiao, Y., Zhu, C., Cheng, X. et al. Role of sarcopenia in Temporal progression trajectory of cardiometabolic diseases: a prospective study in UK biobank. BMC Public Health 25, 1294 (2025). https://doi.org/10.1186/s12889-025-22500-1
